You grew it. Now you have to get inside it.
After weeks of cultivation and days of harvesting, you have a concentrated paste of algal biomass. Every gram of astaxanthin, DHA, lutein, or protein you want is sealed inside cells that evolved to be chemically and mechanically resistant. Getting it out without destroying the compound in the process is one of the most consequential — and underestimated — engineering decisions in algae production.
The cell wall problem is not uniform across species. Spirulina is wrapped in a thin peptidoglycan layer — soft enough that simple mechanical agitation or even digestion is sufficient. Chlorella has a tough, multi-layered sporopollenin wall that resists chemical solvents, enzymatic attack, and moderate mechanical forces. Haematococcus in its cyst stage — the form it takes when astaxanthin accumulates under stress — produces one of the most resilient biological structures known, a trilaminar sheath that functions essentially as armour. The same stress conditions that trigger astaxanthin production also build the fortress wall that traps it. The disruption challenge is baked into the biology.
This module covers the three families of disruption method — mechanical, thermal/chemical, and enzymatic — and then the extraction methods that follow: solvent extraction, supercritical CO₂, and aqueous-phase techniques. The right combination depends on target compound, target purity, target scale, and what your product's regulatory classification allows. Getting it wrong doesn't just mean lost yield — it means degraded compounds, contaminated extracts, or an extraction residue that is worthless instead of sellable.
Typical astaxanthin yield loss if cell wall disruption is incomplete
High-pressure homogenisation — most effective single-pass disruption
Estimated processing cost for sc-CO₂ extraction at pilot scale
Clean-label / solvent-free extracts vs. hexane-extracted equivalents
Three approaches to the same problem, with very different consequences
Cell disruption methods fall into three families: mechanical (force), thermal/chemical (heat, acids, solvents), and biological (enzymes). Each has different energy demands, different effects on product integrity, and different scalability profiles. Most commercial operations use a combination.
Physical force breaks the cell wall through cavitation, shear, or direct impact. Scalable, continuous, no chemical inputs. Primary choice for most commercial operations.
Methods: Bead milling · HPH · UltrasonicationHigh temperature, pH extremes, or osmotic shock compromise wall integrity. Simple to implement at small scale; product degradation risk increases with temperature.
Methods: Autoclaving · Acid/alkali treatment · Freeze-thawCellulases, lysozymes, and other cell wall-degrading enzymes selectively disrupt wall components. Gentle and precise, but expensive and slow. Rarely used at scale alone.
Methods: Cellulase · Lysozyme · Multi-enzyme cocktailsWithin the mechanical family, the choice between methods matters more than the family label. Bead milling is the workhorse of the industry for wet biomass: glass or ceramic beads in a high-speed rotating chamber shear cells against each other and the beads. It handles large volumes continuously, achieves 80–95% disruption efficiency for Chlorella with two to three passes, and costs significantly less per kilogram than alternatives. Its weakness is heat generation — the friction of continuous bead contact raises temperature, which degrades heat-sensitive pigments like chlorophyll and some carotenoids unless active cooling is applied. For Haematococcus, bead milling alone is often insufficient at a single pass because the trilaminar sheath doesn't yield to shear in the same way — operators typically run two to four passes or combine with enzymatic pretreatment.
High-pressure homogenisation (HPH) forces the slurry through a narrow valve at 500–2000 bar, creating extreme turbulence, cavitation, and shear that ruptures nearly everything in its path. A single HPH pass can achieve 90–98% disruption efficiency for most species. The problem is capital cost: a continuous-flow HPH unit capable of processing 1,000 litres per hour costs €200,000–€500,000. At that scale, HPH begins to make sense economically — the energy cost per kilogram of product is lower than bead milling at high throughput. At pilot scale, it is often too expensive to justify.
Ultrasonication — using high-frequency sound waves to create cavitation bubbles that implode and rupture cell walls — is popular at lab scale and small pilot scale because the equipment is inexpensive and easy to operate. At industrial scale it essentially disappears. The reason is energy intensity: achieving uniform sonication in large volumes requires arrays of transducers and enormous energy input, and the economics never compete with bead milling or HPH at scale above a few hundred litres per batch. Sonication is valuable for research and for small-volume high-value applications (cosmetic ingredient batches, for example), but it is not a scale-up path.
Glass or zirconium oxide beads at high rotation shear cells against each other and bead surfaces. Handles wet slurry (15–20% DW). 80–95% disruption in 2–3 passes for Chlorella. Requires active cooling for heat-sensitive compounds.
Forces slurry through a microvalve, creating extreme cavitation and shear. Single-pass efficiency 90–98%. €200,000–€500,000 for industrial units processing 500–2,000 L/hr. Best economics above 10 tonne/year biomass.
Cellulases, hemicellulases, and lysozymes degrade specific wall components. Gentle — preserves pigment integrity. Used as pre-treatment before HPH for Haematococcus cysts, reducing HPH passes needed from 4 to 2. Enzyme cost is €10–€40/kg at current prices.
Ice crystal formation ruptures membranes during freezing; expansion during thawing completes disruption. Effective for Spirulina and thin-walled species. Spray drying dehydrates cells and simultaneously disrupts walls through osmotic shock and heat — commonly used when the product is dry biomass powder rather than an extract.
Disruption opens the door. Extraction decides what you take through it.
Once cells are disrupted, you have a suspension of cell debris, water, proteins, pigments, lipids, carbohydrates, and your target compound. Extraction is the process of selectively capturing the target compound while leaving as much of the rest behind as possible. The selectivity depends on the compound's chemistry — specifically, whether it is hydrophilic (water-loving) or lipophilic (fat-loving). Most high-value algae compounds are lipophilic: astaxanthin, EPA, DHA, lutein, β-carotene. Phycobiliproteins (phycocyanin, phycoerythrin) are hydrophilic and follow a completely different pathway.
The gold standard for high-value lipophilic extracts is supercritical CO₂ (sc-CO₂) extraction. CO₂ above its critical point (31°C, 73.8 bar) behaves as both a gas and a liquid — it has the density of a liquid (penetrates cell material effectively) and the diffusivity of a gas (separates cleanly by simply reducing pressure). The result is an extract with no solvent residue, no thermal degradation (operating temperatures are 35–60°C), and an extractate of extraordinary purity. For astaxanthin specifically, sc-CO₂ achieves 85–95% extraction efficiency with selectivity for the esterified forms that are commercially most valuable. The Kyowa-Hakko (now part of the Haematococcus supply chain) and Algatechnologies production processes both use sc-CO₂ as the primary extraction step for this reason.
The main barrier to sc-CO₂ is capital cost. A production-scale sc-CO₂ unit (processing 100–500 kg biomass per day) costs €300,000–€1,500,000 depending on vessel volume and pressure rating. For a startup, this is either a contract-manufacturing decision (use an established tolling facility in Europe or North America) or a fundraising milestone. The operating cost per kilogram of astaxanthin extract is estimated at €80–€150/kg biomass processed at pilot scale — competitive with solvent extraction once the premium for "solvent-free" regulatory and marketing positioning is factored in, and necessary if you are targeting European markets where hexane residues in food extracts face increasing regulatory pressure.
Organic solvent extraction — hexane, ethanol, acetone — is cheaper and simpler. Hexane is a highly effective solvent for lipophilic compounds including carotenoids and omega-3 rich oils: it dissolves the lipid fraction completely, is then evaporated off, and the crude extract is further purified. Published production economics for hexane-extracted Nannochloropsis EPA oil put extraction costs at €15–€30/kg biomass, compared to €80–€150 for sc-CO₂. The disadvantage is threefold. First, hexane is classified as a hazardous solvent; its residue in food products is tightly regulated (EU maximum residue limit: 1 mg/kg in edible fats). Second, it co-extracts everything lipophilic — chlorophylls, other pigments, oxidised lipids — requiring expensive purification steps to reach a sellable product. Third, it destroys the "clean label" premium: products marketed as natural health ingredients increasingly cannot carry hexane extraction if they are targeting premium positioning. Ethanol is a friendlier solvent with GRAS status in food applications and is preferred for phycobiliprotein extraction and for markets sensitive to hexane.
Phycocyanin (from Spirulina) and phycoerythrin (from Porphyridium) are water-soluble proteins, not lipids. After mechanical disruption, simple aqueous extraction in phosphate buffer pH 7.0 recovers 85–90% of phycocyanin from disrupted biomass. Subsequent purification uses ammonium sulphate precipitation and ion-exchange chromatography. This is fundamentally different from the sc-CO₂ or solvent route — and is why Spirulina processing is much simpler and cheaper than Haematococcus processing.
CO₂ above 31°C and 73.8 bar becomes supercritical — liquid density, gas diffusivity. Extracts lipophilic compounds with no solvent residue. Purity 85–95% for astaxanthin oleoresin. Pressure drop separates extract from CO₂, which is recycled. Capital-intensive (€300K–€1.5M), low operating cost at scale.
Hexane dissolves all lipophilic compounds effectively. Low capex (€20K–€80K for a basic rotary evaporator setup). €15–€30/kg biomass processing cost. Requires solvent residue testing; EU 1 mg/kg MRL in food fats. Not compatible with clean-label premium. Ethanol is preferred alternative for food-grade products — slower but GRAS status.
Water or pH-buffered solution extracts hydrophilic compounds post-disruption. Phycocyanin from Spirulina achieves 85–90% recovery via water extraction at pH 7. Protein extraction from Chlorella using alkaline water (pH 10–11) achieves 60–75% protein recovery. Simple equipment. Downstream purification (centrifugation, precipitation) needed for high-purity products.
The decision between sc-CO₂ and solvent extraction is not a technical decision — it is a market positioning decision made backwards from who your customer is. If you are supplying a German nutraceutical brand that carries the EU organic logo, sc-CO₂ is not optional. If you are supplying an aquaculture feed manufacturer in Vietnam, hexane extraction at half the cost is exactly what they want.
— Extraction economics principle · downstream market determines upstream process
The failure modes nobody puts in the brochure
Cell disruption and extraction appear simple in a process flowchart. In practice, they are where many pilot projects lose yield, lose product quality, or discover that their cost model was built on lab-scale numbers that do not translate to production. Understanding the failure modes before you are in them is the whole point of this module.
Incomplete disruption masking yield loss
Lab-scale disruption methods — sonication, vortex, freeze-thaw — achieve near-100% disruption in small volumes. At 100-litre scale, the same method achieves 40–60% disruption because mixing is inadequate and energy density is insufficient. The operator measures "yield" as the compound recovered from the extract and assumes it is the total available — but 40% may still be locked in intact cells in the pellet. Confirmation test: run a second disruption pass on the discarded pellet and measure recovery. If you get significant additional compound, your first pass is incomplete.
Oxidative degradation during processing
Astaxanthin, β-carotene, EPA, and DHA are highly susceptible to oxidation once extracted from the protective cellular environment. Exposure to air, light, and elevated temperature during disruption and extraction degrades both potency and colour. Industrial operations running sc-CO₂ for astaxanthin work under nitrogen blanket and reduced light. Bead milling for omega-3 rich Nannochloropsis runs chilled to ≤15°C. These precautions add cost but are non-negotiable for premium product quality. A degraded astaxanthin extract fails the spectrophotometric purity test at 480 nm.
Co-extraction contamination
Organic solvents do not distinguish between astaxanthin and chlorophyll — both are lipophilic. A hexane extract of Haematococcus biomass is dark green-brown before purification, not the vivid orange-red of purified astaxanthin. Removing chlorophylls requires saponification (alkaline hydrolysis) or chromatographic purification, each adding cost and potential for astaxanthin loss. This problem is largely avoided with sc-CO₂ extraction at optimised pressure settings, which achieves greater selectivity — another reason the premium markets use sc-CO₂ even though it costs more.
The cell wall determines your method, not your preference
Several pilot-stage companies have selected extraction methods based on economics, then discovered the disruption method they chose doesn't achieve sufficient cell wall opening for their target species. Haematococcus cyst walls are the canonical example: operators who specify bead milling alone (based on Chlorella benchmarks) routinely achieve 50–65% disruption of mature cysts instead of the 90%+ required for acceptable yield. The cyst-stage cell wall is fundamentally different from the vegetative cell wall and requires enzymatic pre-treatment or HPH at higher pressure. The lesson: validate disruption efficiency on your actual production-stage biomass, not literature benchmarks from different culture conditions.
Protein denaturation in combined processes
If the target product is a protein (phycocyanin, Chlorella protein isolate) and the operator also applies heat, high pH, or bead milling with inadequate cooling, the protein denatures — losing its native structure, solubility, and commercial value. Phycocyanin extracted above 45°C loses its characteristic blue colour at 620 nm. Chlorella protein solubility drops sharply above pH 12 or below pH 3. For protein products, disruption method selection must prioritise temperature and chemical gentleness over disruption efficiency — which often means accepting 70–80% disruption yield rather than the 95% achievable with more aggressive methods.
Yield on paper vs yield as a sellable product
Published extraction yields (e.g. "3% astaxanthin in dry biomass") are measured analytically — typically by HPLC after exhaustive extraction with acetone or DMSO in the lab. Commercial extraction yields are 50–80% of the analytical maximum, because commercial methods trade off total extraction efficiency against product purity, cost, and throughput. A company claiming "we recover 90% of our analytical yield" at commercial scale deserves serious scrutiny. Realistic commercial recovery benchmarks: sc-CO₂ for astaxanthin 85–92% of free astaxanthin; hexane for carotenoid oleoresin 70–85%; aqueous for phycocyanin 75–90%.
If SustaBloom pursues astaxanthin, the extraction method is a market segmentation decision, not just an engineering one. Sc-CO₂ extraction is required to access European premium nutraceutical buyers and any customer requiring solvent-free certification. The capital cost (€300K–€1.5M for a production unit) makes this a fundraising milestone, not a day-one capability — the realistic path for a capital-light Indian startup is to grow and harvest Haematococcus biomass and toll-process through an established sc-CO₂ facility (several exist in Germany, Netherlands, and Spain) until the volume justifies in-house capital investment. This is not a compromise — it is the standard entry model for new Haematococcus producers.
The Indian market has a lower extraction barrier for entry than European markets. FSSAI does not currently specify extraction method for algae-derived food ingredients in the same way the EU does. An ethanol-extracted phycocyanin or an ethanol-extracted astaxanthin oleoresin can legally be sold in India as a food colour or health supplement ingredient. This opens a capital-light entry path: ethanol extraction equipment for a 50-litre batch costs ₹5–15 lakhs, versus ₹2–4 crore for a sc-CO₂ setup. The trade-off is that ethanol-extracted products cannot be marketed into premium EU clean-label channels — so the extraction choice locks in your addressable market.
Validate disruption efficiency on your own biomass before specifying processing equipment. The single most avoidable cost error in algae processing is purchasing equipment based on Chlorella disruption benchmarks and then discovering your Haematococcus cysts require a different method. Disruption efficiency should be measured by flow cytometry or microscopy (cell viability staining with propidium iodide) on a 1-litre test batch before any equipment purchase above ₹50,000. This validation costs almost nothing. Getting it wrong on a production unit costs everything.
| Extraction Method | Target Compounds | Capex | Processing Cost/kg | Purity | Market Suitability |
|---|---|---|---|---|---|
| Supercritical CO₂ | Carotenoids · omega-3 oils | €300K–1.5M | €80–150 | High 85–95% | Premium EU/US |
| Hexane extraction | All lipophilic compounds | €20–80K | €15–30 | Medium — needs purification | Commodity feed/industrial |
| Ethanol extraction | Carotenoids · phycobiliproteins | €15–60K | €20–50 | Medium-high | India · GRAS markets |
| Aqueous buffer | Phycocyanin · proteins | €5–20K | €10–25 | Varies 70–90% | Food colourants · proteins |
| Enzymatic lysis only | Polysaccharides · mild pigments | €10–30K | €40–80 | High selectivity | Niche applications |
Astaxanthin oleoresin at 5% purity sells for $500–800/kg. The same astaxanthin at 10% purity sells for $1,200–1,800/kg. The same compound at 97%+ purity (chromatographic grade for cosmetics or pharmaceutical use) commands $3,000–6,000/kg. The extraction and purification steps — not the cultivation — are often where the majority of value is added or destroyed. Investing in extraction quality is not a cost; it is market positioning.
Synthesis questions
Scenario-based. Require specific numbers and named examples. Reveal answers only after attempting.
This configuration has one critical flaw and one viable component. The hexane extraction is defensible for the Indian market — FSSAI does not prohibit hexane extraction for nutraceutical ingredients at the current regulatory stage, and hexane extraction equipment for a 50-litre batch can be set up for ₹5–15 lakhs, well within budget. The problem is the bead milling choice for Haematococcus.
Haematococcus in its astaxanthin-accumulating cyst stage has a trilaminar sporopoillenin outer sheath that bead milling alone typically disrupts to 50–65% efficiency — meaning 35–50% of the astaxanthin remains inaccessible. For Chlorella, bead milling achieves 80–95% disruption and is the standard method. Haematococcus is a different biology. The commercial solution is either HPH at ≥1500 bar (which achieves 90–95% disruption in a single pass) or enzymatic pretreatment with a cellulase cocktail for 2–4 hours before bead milling — the enzyme degrades the trilaminar layer enough for beads to complete the job in 2 passes instead of 6+.
Within a ₹40 lakh budget, a small pilot HPH unit (≤200 bar, ≤10 L/hr) can be sourced from Indian suppliers for ₹8–18 lakhs, or an enzyme pretreatment reactor for ₹2–5 lakhs. The most important single action before purchasing anything is a disruption efficiency validation test: a ₹500 propidium iodide cell viability assay on a 100-mL sample after each disruption method. This test should be run before any equipment purchase above ₹1 lakh. Companies that skip this step and buy equipment based on species group (algae → bead mill) rather than strain-specific validation routinely discover the problem after €100,000 of equipment is in place.
One additional point: ₹40 lakhs is sufficient to build a viable small-scale extraction train if the extraction method is ethanol rather than hexane. Ethanol-extracted astaxanthin oleoresin from Haematococcus is FSSAI-compatible for health supplement classification and avoids the hexane residue testing cost. Total ethanol extraction and recovery equipment at 20-litre batch scale can be configured for ₹12–25 lakhs. The remainder of the budget goes toward disruption equipment and validation.
Your colleague is likely right, and the reasons are predictable. Published lab-scale sc-CO₂ recovery rates of 90–95% for lipophilic compounds are typically measured on exhaustively dried, finely ground biomass processed in a 50–500 mL vessel with complete mixing and optimal residence time. Commercial sc-CO₂ operates under different conditions in every one of those variables.
First, biomass moisture content. SC-CO₂ extraction efficiency drops sharply when biomass moisture exceeds 5–8% dry weight. Commercial harvesting produces biomass at 15–25% dry weight (centrifuge cake) or higher (filter cake). Spray drying to ≤5% moisture adds €30–80/kg biomass processing cost and introduces oxidation risk for EPA. Many labs report yields on freeze-dried biomass — freeze drying is essentially never used commercially because it costs more than the product is worth for most compounds.
Second, mass transfer limitations in large vessels. At 50 mL, CO₂ penetrates the entire biomass volume rapidly. In a 500-litre commercial extractor, channelling — where supercritical CO₂ flows through preferential paths rather than uniformly through the bed — reduces contact between CO₂ and biomass. This is a known engineering challenge; commercial operators manage it with bed packing, agitation, and multiple extraction cycles, but each mitigation adds cost and processing time.
Third, the 94% figure. Published recovery is often calculated as (compound in extract) / (compound measured by exhaustive lab extraction). Commercial extraction is compared against realistic analytical maximum, not theoretical maximum. Realistic commercial sc-CO₂ recovery for EPA from Nannochloropsis is 75–85% — still excellent, and vastly better than hexane extraction for omega-3 ester purity. The practical benchmark is 80% as a working assumption; 85–88% is achievable with optimised operating parameters at ≥500 kg/day throughput. The 94% figure is real — in the specific conditions of that lab. The error is assuming those conditions scale.
The answer requires understanding where Cyanotech and Algatechnologies actually sell and who their buyers are. Both sell into the premium human nutraceutical market — capsules, softgels, and functional beverages in the US, Europe, and Japan, where the end consumer is paying $30–80 for a month's supply of astaxanthin and expects a clean, natural product. The downstream customer — typically a brand like Nutrex Hawaii or a contract manufacturer supplying Whole Foods and iHerb — specifies solvent-free extraction as a contractual requirement because their own certifications (USDA Organic, Non-GMO Project, NSF) prohibit hexane residues or require declaration of processing solvents.
This is the market-backwards logic: the price premium on sc-CO₂-extracted astaxanthin is not €80–150/kg processing cost — it is the entire premium the finished product captures over commodity synthetic astaxanthin. Synthetic astaxanthin (from BASF, Carotenoid GmbH) sells for €800–1,200/kg. Natural Haematococcus astaxanthin sells for €2,500–5,000/kg. The premium is justified in the market by the "natural" positioning, and sc-CO₂ extraction is part of what makes that claim defensible and certifiable. A hexane-extracted natural astaxanthin at €1,400/kg is neither the cheapest option (synthetic is) nor the most premium option (sc-CO₂ is). It occupies an unclaimed middle ground with no compelling positioning.
There is also a technical reason. Hexane extraction of Haematococcus co-extracts a significant amount of chlorophyll, requiring saponification to produce an oleoresin with acceptable colour spec (the visual orange-red of the capsule is a quality signal consumers recognise). Sc-CO₂ at optimised pressure settings — typically 300–350 bar, 50–60°C — has inherently higher selectivity for astaxanthin esters over chlorophylls because chlorophylls have a different polarity signature. The extract comes off the separator substantially purer, reducing downstream purification costs. At €3,500/kg sell price, paying €100–150/kg more for a cleaner extraction process is a straightforwardly rational decision.
Starting with 200 kg dry weight biomass at 14% phycocyanin content: theoretical maximum phycocyanin = 28 kg per month. The A620/A280 purity ratio of 0.7 is the lower threshold for food-grade crude phycocyanin (pharmaceutical-grade requires ≥4.0, which requires further chromatographic purification; cosmetics-grade is typically ≥1.5).
The extraction process for Spirulina phycocyanin is as follows. First, disruption: Spirulina has a thin peptidoglycan wall. Bead milling at 5,000–7,000 rpm for one pass or two freeze-thaw cycles achieves 85–95% disruption. Alternatively, high-speed homogenisation at moderate pressure (50–100 bar) is sufficient. No enzymatic pretreatment needed. Second, aqueous extraction: disrupted biomass is resuspended in phosphate buffer pH 7.0 at 1:5 biomass:buffer ratio (w/v), stirred for 60 minutes at 4°C. Low temperature prevents protease activity and colour degradation. Phycocyanin dissolves into the aqueous phase; chlorophyll and membrane lipids remain in the debris. Third, centrifugation: 8,000–12,000 × g for 20 minutes. Supernatant contains phycocyanin; pellet (cell debris) is discarded or redirected to protein extraction. Fourth, filtration: supernatant through 0.2 μm membrane to remove remaining particulates. At this stage, A620/A280 is typically 0.4–0.6 — not yet meeting the 0.7 spec.
To reach A620/A280 ≥ 0.7: ammonium sulphate precipitation at 35–55% saturation precipitates the pigment-protein complex selectively, redissolving in minimal buffer raises the purity ratio to 0.7–0.9. This additional step adds approximately 20–30% processing time but is standard for food-grade phycocyanin.
Yield calculation: theoretical 28 kg × 85% aqueous extraction recovery × 75% precipitation recovery = approximately 17.9 kg of crude phycocyanin extract at A620/A280 ≥ 0.7. At current market prices for food-grade phycocyanin (₹8,000–15,000/kg), monthly revenue from phycocyanin alone = ₹1.4–2.7 lakhs from 200 kg biomass. This illustrates why Spirulina phycocyanin is attractive for Indian producers — the extraction is simple, aqueous, requires no hazardous solvents, and the domestic blue food colourant market (ice cream, beverages, sweets) is growing rapidly after FSSAI approval of natural blue colourants.
This is a clever reframing of a real limitation, and it is genuinely appropriate for some markets while being a fundamental problem for others. Understanding when it is each is the key commercial insight.
The whole-cell biomass approach is legitimate and commercially successful in specific segments. Spirulina powder sold as a whole-food supplement is the largest single microalgae product globally by volume — it is sold without extraction because the market does not require isolation of phycocyanin or any other compound. The buyer is consuming the whole cell matrix and values the combination of protein, pigments, vitamins, and minerals. Similarly, Chlorella tablets sold in Japan and Germany are whole-biomass products. "Zero extraction losses" in this context is literally true and is the correct business model.
However, claiming "zero extraction losses" for Haematococcus astaxanthin in whole-cell format is a significant technical misdirection. The human gut cannot efficiently disrupt the mature Haematococcus cyst wall — bioavailability of astaxanthin from whole dried Haematococcus cells is significantly lower (some studies report 30–50% lower bioavailability) than from extracted oleoresin or encapsulated extract. Regulators recognise this: the FDA's NDI notification for natural astaxanthin specifies processing conditions, and EFSA's Novel Food evaluations of Haematococcus products have historically required data on cell disruption and bioavailability.
The deeper point is that "extraction loss" framing assumes the comparison is between a perfect extraction and an imperfect one. In practice, the comparison is between extracting to high purity (losing some yield but maximising value per gram sold) and not extracting (zero loss but also zero concentration and potentially impaired bioavailability). A 5 mg astaxanthin capsule using extracted oleoresin contains a physically small, precisely dosed amount. An equivalent dose in whole-cell powder requires ingesting several grams of biomass — a formulation that many functional food and supplement formats cannot accommodate. The competitor's "advantage" works in the whole-food supplement market. It does not work in pharmaceutical applications, cosmetics actives, or precision-dosed functional food ingredients. Those markets simply are not accessible with whole biomass.